Author

Ding‐Chao Rong

Observed names: D. Rong, Ding-Chao Rong, Dingchao Rong

Institution: Shaoyang University

Observed institutions: Central South University, Shaoyang University, Third Affiliated Hospital of Guangzhou Medical University, Third Affiliated Hospital of Sun Yat-sen University, Xiangya Hospital Central South University, Guangzhou Medical University

ORCID: 0009-0002-8414-7845

Observed ORCID: 0009-0002-8414-7845

OpenAlex ID: A5014475527

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

2023 · Qian Hu, Qihui Bian, et al. · Frontiers in Bioengineering and Biotechnology · 397

ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions

2025 · Yuan-Shen Chen, Hui-Xiang Tian, et al. · Molecular Biomedicine · 101

Human umbilical cord mesenchymal stem cells-derived extracellular vesicles facilitate the repair of spinal cord injury via the miR-29b-3p/PTEN/Akt/mTOR axis

2021 · Xiao Xiao, Weiwei Li, et al. · Cell Death Discovery · 73

Anoikis in cell fate, physiopathology, and therapeutic interventions

2024 · Jie Mei, Xue‐Yao Jiang, et al. · MedComm · 62

Clinical characteristics and radiological features of children infected with the 2019 novel coronavirus

2020 · Y. Lu, H. Wen, et al. · Clinical Radiology · 48

Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer

2023 · Hui‐Xiang Tian, Jie Mei, et al. · Small · 30

The romantic history of signaling pathway discovery in cell death: an updated review

2023 · Lei-Yun Wang, Xing-Jian Liu, et al. · Molecular and Cellular Biochemistry · 22

CSF3 Is a Potential Drug Target for the Treatment of COVID-19

2021 · Chao Fang, Jie Mei, et al. · Frontiers in Physiology · 21

Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer

2025 · Jie Mei, Hui-Xiang Tian, et al. · Journal of Advanced Research · 20

Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future

2025 · Jie Mei, Yuan-Shen Chen, et al. · The Innovation Medicine · 6

Prognostic model for osteosarcoma: RNA diagnostics, tumor microenvironment and immunotherapy response

2025 · Ding-Chao Rong, Xu Rong, et al. · Journal of Orthopaedics

Atezolizumab monotherapy as first-line treatment for non-small cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a cost-effectiveness analysis in the USA

2024 · Biao Li, Dingchao Rong, et al. · BMJ Open

Works count: 12

Citation count: 780

H-index: 9

I10-index: 9